SCHEMBL19856025

SCHEMBL19856025

C=CCCc1ccc(-c2ccc(NC(=O)C=C)cc2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
THRA P10827 1/20 0.58
THRB P10828 1/20 0.58
TGM2 P21980 11/20 0.51
F13A1 P00488 2/20 0.51
TGM1 P22735 2/20 0.51
LMNA P02545 1/20 0.51
TGM3 Q08188 1/20 0.51
TDP2 O95551 1/20 0.44
LPAR2 Q9HBW0 1/20 0.44
LPAR3 Q9UBY5 1/20 0.44
PPARG P37231 1/20 0.43
KDR P35968 1/20 0.42
TEK Q02763 1/20 0.42
CDK7 P50613 1/20 0.41
CCNH P51946 1/20 0.41
MNAT1 P51948 1/20 0.41
FGFR1 P11362 1/20 0.41
FGFR4 P22455 1/20 0.41
KDM4E B2RXH2 1/20 0.41
ALDH1A1 P00352 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19854543 0.83 THRA (0.74) THRATHRBTGM2F13A1TGM1
SCHEMBL20456504 0.81 THRA (0.61) THRATHRBTGM2F13A1TGM1
SCHEMBL19855850 0.81 THRB (0.89) THRATHRBTGM2ALDH1A1MAPT
SCHEMBL8867192 0.80 THRA (0.65) THRATHRBTGM2F13A1TGM1
SCHEMBL8867209 0.80 THRA (0.65) THRATHRBTGM2F13A1TGM1
SCHEMBL19854552 0.80 THRA (0.61) THRATHRBTGM2F13A1TGM1
SCHEMBL12265208 0.79 THRA (0.63) THRATHRBTGM2F13A1TGM1
SCHEMBL12832351 0.79 THRB (0.77) THRATHRBTGM2F13A1TGM1
SCHEMBL6279031 0.78 TGM2 (0.59) THRATHRBTGM2F13A1TGM1
SCHEMBL440756 0.78 TGM2 (0.63) THRATHRBTGM2F13A1TGM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210214615-A1 LIQUID CRYSTAL DISPLAY DEVICE AND DISPLAY UNIT JNC CORPORATION (JP) 2021-07-15 US disclosed
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 US disclosed
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE JNC CORPORATION (JP) 2018-07-12 US disclosed
WO-2018025974-A1 LIQUID-CRYSTAL DISPLAY ELEMENT AND DISPLAY DEVICE JNC株式会社 2018-02-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180195005-A1 POLYMERIZABLE POLAR COMPOUND, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE SP1, MBD2, PAXBP1 THRA 3929/4885THRB 3939/4885TGM2 4006/4885
US-10662379-B2 Polymerizable polar compound, liquid crystal composition and liquid crystal display device SP1, MBD2, PAXBP1 THRA 3929/4885THRB 3939/4885TGM2 4006/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.